[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608729":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":36,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"HemoCept Inc.","INDUSTRY",null,[9],{"name":10,"affiliation":11,"role":12},"Jamie Doucet, MD","Boulder Heart","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Katharine Adkins","CONTACT","303-442-2395","kathari.adkins@bch.org",[20],{"facility":11,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"RECRUITING","Boulder","Colorado","80303","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-105.27055,40.01499,{"lat":31,"lon":30},[34,35],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},{"name":10,"role":12,"phone":7,"phoneExt":7,"email":7},{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100608729","detecting-changes-in-arterial-blood-volume-and-cardiac-efficiency-100608729",false,"NCT07205341","Detecting Changes in Arterial Blood Volume and Cardiac Efficiency","A Pilot Clinical Study to Assess Correlation Between Arterial Blood Volume Status and Cardiac Efficiency, and HemoCept Device Data in Trans-Aortic Valve Replacement (TAVR} Surgery","Inclusion Criteria:\n\n* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.\n* Subjects can be any gender but must be between (and including) the ages of 18 and 80.\n* Subject ls being treated by the participating healthcare facility .\n\n  ., Subject requires a trans-aortic valve replacement.\n* Subject is able and willing to provide informed consent and HIPM authorization.\n* Subject is able and willing to meet all study requirements.\n\nExclusion Criteria:\n\n* Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.\n* Subject has a personal medical history that includes:\n\n  * Long O-T syndrome\n  * Cardiac channelopathies\n  * Seizures","ALL","18 Years","80 Years",{"count":49,"type":50},20,"ESTIMATED","OBSERVATIONAL","The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.",[54],"Aortic Valve Stenosis","2026-04-09",{"date":57,"type":58},"2026-04-13","ACTUAL",{"date":60,"type":58},"2025-04-29",{"date":62,"type":50},"2026-09",{"name":5,"class":6},1]